Ana Marquez Discusses the Difficulties That Sites Face Getting Paid and How DrugDev Has Helped
We caught up with Ana Marquez, Founder & CEO, Marquez Clinical Site Partners at this year’s SCOPE conference and asked for her insights into the clinical trials industry.
SCOPE 2016 in Pictures
We had fantastic time at SCOPE again this year. From our pre-SCOPE kickoff Happy Hour with Praxis, CISCRP and CHI to our numerous speakers and panel members. Here’s some pictures…
Where to find DrugDev at SCOPE 2016
Don’t miss these SCOPE sessions featuring DrugDev experts: Monday, February 22 Pre-SCOPE Kickoff Happy Hour with DrugDev, Praxis, CISCRP and CHI Join us for casual networking, drinks and fun door…
Can We Shift Investigators from “1 and done” to Repeat Performers
The challenge of the ‘1 and done’ investigators (i.e., investigators who do not return to perform a second clinical trial) is one that has been talked about for years. Why…
Start SCOPE on the Right Foot
Join DrugDev, Praxis, CHI and CISCRP for our annual pre-SCOPE happy hour. Plenty of drinks and apps will be served. Please RSVP by February 17 to join in on the…
SCOPE 2016 – How One (Golden) Number Can Transform Clinical Trials
For years pharmaceutical companies and CROs have struggled to collect, clean and collate site data from disparate sources so they can make better decisions about site feasibility and selection. With…
SCOPE 2016 – Faces in the Crowd: Why We Do What We Do
The concept of the “Abstract Patient” has become too common in our industry, especially at conferences where we gather to discuss ideas and debate the best ways to support them….
SCOPE 2016 – Sneak Preview: Speed Site Activation Using Collaborative Technology for Contracting and Essential Site Doc
Join DrugDev President & CEO Ibraheem (Ibs) Mahmood and Melissa (Liss) Easy, Founder of DrugDev and President of Site Identification and Activation for lunch Wednesday, February 24 at SCOPE for…
Why Technology Fails
Join Hugo Stephenson MD, Chairman of DrugDev, founder of the DrugDev Innovation lab and Primary Investigator on Tuesday, February 23, 4pm at SCOPE as he facilitates a discussion on Why…